Moneycontrol PRO
Upcoming Webinar:Prashant Shah explains ‘Irrelevance of Bull & Bear Markets for Success in Technical Analysis’. Register For Free!

Deepak Nitrite may move to Rs 496: AnandRathi

The company’s new Greenfield expansion plan at Dahej, Gujarat for manufacturing phenol (2, 00,000 ton/year) and acetone (1, 20,000T/year) has demonstrated successful operations and is currently operating at over 90 percent utilization levels.

January 10, 2020 / 08:58 AM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

AnandRathi

Deepak Nitrite currently operates its businesses with Bulk Chemicals segment, Fluorescent & whitening agents segment, Fine & speciality segment and Phenolics through its 100 percent subsidiary Deepak Phenolics, each contributing 33 percent, 15 percent, 19 percent and 33 percent to the revenues respectively.

During the latest results company has reported consolidated revenues of Rs 10,033 million as against Rs 4,611 million, a growth 117 percent, YoY. The growth excluding phenolic business was 32.5 percent which was mainly due to higher volumes and improved pricing in basic chemicals & Performance Products segment and remaining was contributed by Phenolics business.

On profitability front, the company’s consolidated EBITDA margins stood 25 percent at Rs 2,505 million in Q2-FY19 as against 13.9 percent at Rs 642 million and its PAT margins stood 15 percent at Rs 1,501 million as against 5.2 percent at Rs 239 million in Q2-FY19.

With the latest results reflecting positive outcome of company’s increased focus on adding high value products and moving higher in the value chain to improve its profitability in long term bodes well for its base business which should continue to show improvement in margins.

Close

The company’s new Greenfield expansion plan at Dahej, Gujarat for manufacturing phenol (2, 00,000 ton/year) and acetone (1, 20,000T/year) has demonstrated successful operations and is currently operating at over 90 percent utilization levels.

The company is also incurring capex on development of downstream products for Acetone and same is expected to be commissioned towards the end of this financial year. All these should result in more sustained and profitable growth for the company.

We expect phenolic business to show improved profitability and any expected decline in temporary higher DASDA prices should offset the bottom line and -also company’s forward integration in form of Acetone derivatives opens up new value addition prospects for the company.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Moneycontrol Contributor
first published: Jan 6, 2020 08:57 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark